Company launches initiative to become a dedicated AI infrastructure partner for the biotechnology industry - to deploy secure, on-premises AI systems directly within client environments where propriet ...

Company launches initiative to become a dedicated AI infrastructure partner for the biotechnology industry — to deploy secure, on-premises AI ...

BioAnalysis launches BASIS 2.0, its next-gen GMP-compliant AUC software for gene therapy. Higher throughput, one-click ...

Syntis Bio, Inc. a clinical-stage biopharmaceutical company advancing novel oral therapeutics that uniquely leverage the small intestine, today announced that the first patient has been dosed in the ...

Japan's synthetic biology market is poised for growth due to increased demand for bio-products and advances in CRISPR and DNA synthesis. Key opportunities lie in healthcare, agriculture, and ...

BioAtla has engaged Tungsten Advisors as the Company’s exclusive strategic financial advisor. There can be no assurance that this process will result in any such transaction. BioAtla does not intend ...

Biobased testing reveals the percentage of biobased versus fossil carbon content in a given sample.Biobased carbon testing helps manufacturers develop materials that mee ...

Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...

Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening of its new Early Phase Center of Excellence, a state of the art 78,000 square foot facility located in Costa Mesa, ...

Avid Bioservices Inc., a dedicated biologics CDMO, has opened its new Early Phase Center of Excellence, a 78,000 square foot ...

In this GEN webinar Ray Zhang, PhD, associate director, QC-Analytics at Franklin Biolabs will introduce the principles of mass photometry and highlight where it adds value across the analytical ...

BioTechnique expands QC services with advanced analytics, lyophilization development, microbiology, monitoring, and ...